Headline News

The FDA has approved obecabtagene autoleucel for the treatment of adults with relapsed refractory B-cell precursor acute lymphoblastic leukemia.

ORLANDO — Using SMART goals can improve interpersonal educational programs, according to an expert.

ORLANDO — Lifestyle medicine interventions can improve medical students’ well-being and reduce physician burnout, according to an expert.

Low-level lead poisoning remains prevalent across the United States and globally, warranting screening and identification of those at highest risk, according to a recently published review.

PHILADELPHIA— AI-assisted-colonoscopy significantly increased the number of colonoscopy procedures in which only benign lesions were removed without additional adenomatous polyps, according to data at the ACG Annual Scientific Meeting.

As a physician trained in India, I saw the devastating impact of infectious diseases like TB, malaria and waterborne illnesses, and the profound difference public health interventions can have. That led to my career in global health.

Epinephrine autoinjectors may have limited effectiveness in helping patients survive anaphylaxis events, according to a review published in Clinical and Experimental Allergy.

What risks should we accept in exchange for a miracle?

Patients using testosterone replacement therapy for at least 3 months may have an increased risk for ACL injuries, according to recently published data.

Infection prevention staff at Boston Children’s Hospital learned that the complexity of certain tasks is an important factor for determining staffing needs, rather than just using the number of beds.